Evidence map›Paper›PMID 38081161›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2024

Any Decrease in Lung Function is Associated With Worse Clinical Outcomes: Post Hoc Analysis of the IMPACT Interventional Trial.

MeiLan K Han, Gerard J Criner, David M G Halpin, Edward M Kerwin, Lee Tombs, David A Lipson, Fernando J Martinez, Robert A Wise, Dave Singh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?American journal of respiratory and critical care medicine · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

MeiLan K HanDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, United States.
Gerard J CrinerLewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States.
David M G HalpinUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, United Kingdom.
Edward M KerwinClinical Research Institute and Altitude Clinical Consulting, Medford, Oregon, United States.
Lee TombsPrecise Approach Ltd, London, United Kingdom.
David A LipsonGSK, Collegeville, Pennsylvania, United States.
Fernando J MartinezDivision of Pulmonology and Critical Care Medicine, Weill Cornell Medicine, New York, New York, United States.
Robert A WiseDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Dave SinghCentre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, University of Manchester, Manchester University National Health Service Foundation Trust, Manchester, United Kingdom.

Funding

GlaxoSmithKline NCT02164513
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic obstructive pulmonary diseaseexacerbationsforced expiratory volume in 1 secondhealth statustriple therapy

Identifiers

PMID38081161
PMCPMC10913929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.